| Since methicillin-resistant Staphylococcus aureus (MRSA) was first identified in 1961, this organism has become one of the most significant emerging pathogens. This study address the current lack of statewide MRSA prevalence estimates in Texas by characterizing the impact that MRSA has on Texas mortality. Of the 197 death certificates listing Staphylococcus as the underlying cause of death in 2004, medical records were acquired for 77 individuals. Approximately 67.5% (52/77) of the staphylococcal related deaths were positively identified as MRSA with the prevalence highest in females (74%), Blacks (71%), older individuals (69%), and in the South West Region of Texas. Vancomycin and linezolid remained as some of the few antibiotics that demonstrated low levels of resistance. MRSA is a significant burden on the Texas healthcare system and steps need to be taken to ensure vancomycin remains a viable treatment option. |
